NEW YORK (GenomeWeb News) – Exosome Diagnostics has raised $7 million toward a goal of $8.5 million, it said in a regulatory filing on Thursday.

In an amended Form D filed with the US Securities and Exchange Commission, the New York-based molecular diagnostic firm said that the types of securities offered were in the form of debt; option, warrant, or other right to acquire another security; and security toe be acquired upon exercise of option, warrant, or other right to acquire security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.